UNSPSC 51112506: Chlormethine hydrochloride

This classification denotes a nitrogen mustard compound with the molecular formula C5H11Cl2N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L0MR697HHI, chemically known as 2,2-dichloro-n-methyldiethylamine but more generally known as chlormethine hydrochloride, which bears US NIH Compound Identifier 4033. European Medicines Agency schedules Chlormethine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01220MIG.

Most nations, for tariff and trade purposes, schedule chlormethine hydrochloride under HS 29211980. SMILES: CN(CCCL)CCCL.CL.

UNSPSC 51112506 Chlormethine hydrochloride, a Commodity code, addresses the procurement of this nitrogen mustard chemotherapy agent by state and local health systems, correctional medical facilities, and public hospitals. State and local government buyers source this pharmaceutical for inpatient oncology programs and specialized cancer treatment centers within their jurisdictions. The code covers the active pharmaceutical ingredient and finished pharmaceutical preparations used in chemotherapy regimens, typically procured through established supplier contracts or cooperative purchasing agreements that leverage group purchasing organization (GPO) networks common in public healthcare settings.

The source contains no recent state and local contract opportunities tagged to this code. Without posted solicitations or awarded contracts in the recent-opportunities record, no geographic concentration or representative procurement activity can be characterized. Given the specialized nature of this chemotherapy agent and typical public-sector procurement patterns for pharmaceutical oncology supplies, activity under this code likely concentrates among state departments of health, state correctional systems, county health departments, and large municipal or regional hospital networks, though the source does not support specific issuance frequency or jurisdictional standouts.